637 results on '"van den Hoogen, F"'
Search Results
2. Oorsuizen
3. Oorsuizen
4. TGFβ-mediated expression of TGFβ-activating integrins in SSc monocytes: disturbed activation of latent TGFβ?
5. Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
6. POS0078 COMPARING METHOTREXATE MONOTHERAPY WITH METHOTREXATE PLUS LEFLUNOMIDE COMBINATION THERAPY IN PSORIATIC ARTHRITIS: A RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND CLINICAL TRIAL (COMPLETE-PsA)
7. POS0652 LONG-TERM EFFECTIVENESS OF ULTRA-LOW DOSES OF RITUXIMAB IN RHEUMATOID ARTHRITIS
8. OP0261 TREAT-TO-TARGET DOSE REDUCTION AND WITHDRAWAL STRATEGY OF TNF INHIBITORS IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: A RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL
9. POS0646 NON-MEDICAL SWITCHING FROM TOCILIZUMAB TO SARILUMAB IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY
10. Oorsuizen
11. Additional file 1 of Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
12. Additional file 3 of Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
13. Additional file 2 of Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
14. Additional file 4 of Patient involvement in basic rheumatology research at Nijmegen: a three year’s responsive evaluation of added value, pitfalls and conditions for success
15. The use of gentamicin-impregnated collagen sponges (Garacol®/Duracoll®) in cochlear implant infections: our experience in four cases
16. POS0343 RITUXIMAB IS SUPERIOR TO PLACEBO IN POLYMYALGIA RHEUMATICA
17. POS0193 DAS28-CRP GUIDED TREAT-TO-TARGET TAPERING OF TUMOR NECROSIS FACTOR INHIBITORS IN PSORIATIC ARTHRITIS: A RETROSPECTIVE COHORT STUDY.
18. Response to: ‘Are autoantibodies to RNA-polymerase III to be incorporated in routine diagnostic laboratory algorithms for systemic autoimmune rheumatic diseases?’ by Jan Damoiseaux
19. Acute upper airway failure and mediastinal emphysema following a wire-guided percutaneous cricothyrotomy in a patient with severe maxillofacial trauma
20. Use and usability of the Dr. Bart app and its relation with health care utilization and clinical outcomes in people with knee and/or hip osteoarthritis
21. Economic evaluation of the Dr. Bart app in people with knee and/or hip osteoarthritis
22. Systemic sclerosis: State of the art on clinical practice guidelines
23. Effect ot the Dr. Bart application on healthcare use and clinical outcomes in people with osteoarthritis of the knee and/or hip in the Netherlands: A randomized controller trial
24. Economic evaluation of the Dr. Bart app in people with knee and/or hip osteoarthritis
25. Use and usability of the Dr. Bart app and its relation withc clinical outcomes in people with knee and/or hip osteoarthritis
26. Improving quality of care in rheumatoid arthritis and associated comorbidities
27. Behandlung der systemischen Sklerose
28. Improving quality of care in rheumatoid arthritis and associated comorbidities
29. Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbidities
30. Autologous hematopoietic stem cell transplantation for autoimmune diseases
31. Salivary duct ligation for anterior and posterior drooling: Our experience in twenty-one children
32. Giant laryngoceles: a cause of upper airway obstruction
33. Report from the EULAR ACR Scleroderma Classification Criteria Committee
34. Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres
35. THU0412 EFFECT OF METFORMIN ON CLINICAL GOUT OUTCOMES IN GOUT PATIENTS WITH DIABETES MELLITUS
36. FRI0209 EFFECTS OF ADD-ON METHOTREXATE IN POLYMYALGIA RHEUMATICA PATIENTS: A RETROSPECTIVE STUDY
37. FRI0629-HPR USE AND USABILITY OF THE DR. BART APP AND ITS RELATION WITH CLINICAL OUTCOMES IN PEOPLE WITH KNEE AND/OR HIP OSTEOARTHRITIS
38. AB0505 SEASONAL INFLUENCE IN PMR: NOT ONLY SUMMER, BUT WINTER IS COMING TOO
39. AB0582 DIAGNOSING SYSTEMIC SCLEROSIS WITH PHOTOACOUSTIC AND HIGH-FREQUENCY ULTRASOUND IMAGING
40. OP0072 IDENTIFYING POLYMYALGIA RHEUMATICA RELAPSE AND ITS ASSOCIATIONS IN A RETROSPECTIVE COHORT
41. OP0155-HPR EFFECT OF THE DR. BART APPLICATION ON HEALTHCARE USE AND CLINICAL OUTCOMES IN PEOPLE WITH OSTEOARTHRITIS OF THE KNEE AND / OR HIP IN THE NETHERLANDS; A RANDOMIZED CONTROLLED TRIAL
42. AB1314-HPR ECONOMIC EVALUATION OF THE DR. BART APP IN PEOPLE WITH KNEE AND/OR HIP OSTEOARTHRITIS
43. THU0448 NO DIFFERENCE IN GOUT FLARES AFTER INITIATION OF URATE LOWERING THERAPY BETWEEN ONCE OR TWICE DAILY 0.5 MG COLCHICINE PROPHYLAXIS
44. Oorsuizen
45. Fall incidence and fall risk factors in people with rheumatoid arthritis
46. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
47. A large multicentre analysis of CTGF −945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype
48. An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
49. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy
50. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.